1. Home
  2. ANAB vs DSGR Comparison

ANAB vs DSGR Comparison

Compare ANAB & DSGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ANAB

AnaptysBio Inc.

HOLD

Current Price

$62.39

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Logo Distribution Solutions Group Inc.

DSGR

Distribution Solutions Group Inc.

HOLD

Current Price

$27.05

Market Cap

1.3B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
ANAB
DSGR
Founded
2005
1952
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Machinery/Components
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.3B
IPO Year
2015
1995

Fundamental Metrics

Financial Performance
Metric
ANAB
DSGR
Price
$62.39
$27.05
Analyst Decision
Buy
Buy
Analyst Count
12
1
Target Price
$71.67
$35.00
AVG Volume (30 Days)
570.6K
58.8K
Earning Date
05-08-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
91.02
212.50
EPS
N/A
0.01
Revenue
$234,603,000.00
$1,980,023,000.00
Revenue This Year
N/A
$5.35
Revenue Next Year
$52.14
$3.79
P/E Ratio
N/A
$2,720.00
Revenue Growth
157.01
9.75
52 Week Low
$17.11
$19.02
52 Week High
$73.30
$33.80

Technical Indicators

Market Signals
Indicator
ANAB
DSGR
Relative Strength Index (RSI) 56.57 46.04
Support Level $52.32 $26.98
Resistance Level $67.69 $28.03
Average True Range (ATR) 3.27 0.72
MACD 0.87 -0.09
Stochastic Oscillator 54.78 17.50

Price Performance

Historical Comparison
ANAB
DSGR

About ANAB AnaptysBio Inc.

AnaptysBio Inc is a clinical-stage biotechnology company. The company is focused on developing antibody product candidates for unmet medical needs in inflammation and immuno-oncology. The company is developing immune cell modulating antibodies, including two wholly owned checkpoint agonists in clinical-stage development, for autoimmune and inflammatory diseases; rosnilimab, PD-1 agonist in a Phase 2b trial for the treatment of moderate-to-severe rheumatoid arthritis (RA) and a Phase 2 trial for the treatment of moderate-to-severe ulcerative colitis (UC); and ANB032, BTLA agonist, in a Phase 2b trial for the treatment of moderate-to-severe atopic dermatitis (AD).

About DSGR Distribution Solutions Group Inc.

Distribution Solutions Group Inc is a specialty distribution company providing value-added distribution solutions to the maintenance, repair and operations (MRO), original equipment manufacturer (OEM) and industrial technology markets. The company operates through four reportable segments: Lawson, TestEquity, Gexpro Services and Canada Branch Division. Lawson distributes specialty products and services to the industrial, commercial, institutional and government MRO marketplace. TestEquity, which generates maximum revenue, distributes test and measurement equipment and solutions, industrial and electronic production supplies and vendor managed inventory programs. Gexpro Services is a supply chain solutions provider. The company generates majority of its revenue from United States.

Share on Social Networks: